The center is planned to start operations in the third quarter. The project is financed by a 48 million euro ILTE loan and company funds, company representatives told BNS.
Read more Peteris Magyaras threatens to remove Hungarian President Tamás Sulyok
“We appreciate Northway Biotech’s ambition to develop advanced future medical technologies in Lithuania and see great potential for this project in international markets. The life sciences industry is very important to us, and we see its huge potential,” said Giedrė Gečiauskienė, a member of the ILTE board and head of the Client Financing Service, in a statement.
